Main lines of research on the Fatty Liver Diesase

Reading time: 1 min

  1. Pathogenic mechanisms of the disease: evaluation of intrahepatic molecular and extrahepatic mechanisms, such as microbiota, adipose tissue and alterations in systemic immunity.
  2. Non-invasive diagnostic and prognostic biomarkers for diagnosing and identifying patients at risk of disease progression.
  3. Treatments for the disease.
  4. Evaluation of better screening strategies, in the field of public health, to detect patients in the early stages of the disease and have a good flow of diagnosis and referral from primary care to hospital.
  5. Evaluation of the most effective, educational nursing interventions for sustained weight loss and lifestyle changes.

Substantiated information by:

Isabel Graupera Garcia-Milà
Marta Cervera Carbonell
Pere Ginès Gibert

Published: 19 August 2022
Updated: 26 August 2022

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.


Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.